Fed. Circ. Backs IP Extension For Photocure's Metvixia
A federal appeals court has affirmed a lower court's decision to grant Norwegian pharmaceutical company Photocure ASA a two-year extension on a patent for skin cancer treatment Metvixia....To view the full article, register now.
Already a subscriber? Click here to view full article